Swiss National Bank
ABEO icon

Swiss National Bank’s Abeona Therapeutics ABEO Stock Holding History

Swiss National Bank’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,496
Closed -$141K – 2508
2019
Q3 		$141K Hold
2,496
– – ﹤0.01% 2512
2019
Q2 		$298K Buy
2,496
+492
+25% +$82.5K ﹤0.01% 2514
2019
Q1 		$369K Hold
2,004
– – ﹤0.01% 2432
2018
Q4 		$358K Hold
2,004
– – ﹤0.01% 2444
2018
Q3 		$641K Hold
2,004
– – ﹤0.01% 2348
2018
Q2 		$802K Hold
2,004
– – ﹤0.01% 2292
2018
Q1 		$719K Hold
2,004
– – ﹤0.01% 2264
2017
Q4 		$794K Buy
+2,004
New +$829K ﹤0.01% 2221

Other funds holding ABEO

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Swiss National Bank's ABEO Position: Q4 2019 in Review

Swiss National Bank sold out of Abeona Therapeutics (ABEO) in Q4 2019, closing a stake of 2,496 shares — an estimated $141K sold.

Swiss National Bank first reported a position in ABEO in Q4 2017 and held it in 8 quarters. The position peaked at $802K in Q2 2018. 87 funds tracked by Wall St. Rank hold ABEO as of Q4 2019.

  • Swiss National Bank reported no remaining Abeona Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Swiss National Bank sold 2,496 Abeona Therapeutics shares in Q4 2019, an estimated $141K.
  • Swiss National Bank first reported a position in Abeona Therapeutics in Q4 2017 and held it in 8 quarters.
  • Swiss National Bank's Abeona Therapeutics position peaked at $802K in Q2 2018.
  • 87 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2019.

Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.